These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35074404)
1. Chronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain. Richer K; Hamilton J; Delis F; Martin C; Fricke D; Yao R; Sajjad M; Blum K; Hadjiargyrou M; Komatsu D; Thanos PK Brain Res; 2022 Apr; 1780():147799. PubMed ID: 35074404 [TBL] [Abstract][Full Text] [Related]
2. Abstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain. Arnavut E; Hamilton J; Yao R; Sajjad M; Hadjiargyrou M; Komatsu D; Thanos PK Synapse; 2022 Aug; 76(9-10):17-30. PubMed ID: 35730134 [TBL] [Abstract][Full Text] [Related]
3. Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects. Carias E; Fricke D; Vijayashanthar A; Smith L; Somanesan R; Martin C; Kalinowski L; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK Behav Brain Res; 2019 Jan; 356():189-196. PubMed ID: 30149034 [TBL] [Abstract][Full Text] [Related]
4. Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects. Kalinowski L; Connor C; Somanesan R; Carias E; Richer K; Smith L; Martin C; Mackintosh M; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK Dev Psychobiol; 2020 Mar; 62(2):170-180. PubMed ID: 31456229 [TBL] [Abstract][Full Text] [Related]
5. Abstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner. Connor C; Hamilton J; Robison L; Hadjiargyrou M; Komatsu D; Thanos P Curr Pharm Des; 2022; 28(4):331-338. PubMed ID: 33504296 [TBL] [Abstract][Full Text] [Related]
6. Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period. Martin C; Fricke D; Vijayashanthar A; Lowinger C; Koutsomitis D; Popoola D; Hadjiargyrou M; Komatsu DE; Thanos PK Pharmacol Biochem Behav; 2018 Sep; 172():22-32. PubMed ID: 30030127 [TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior. Thanos PK; Robison LS; Steier J; Hwang YF; Cooper T; Swanson JM; Komatsu DE; Hadjiargyrou M; Volkow ND Pharmacol Biochem Behav; 2015 Apr; 131():143-53. PubMed ID: 25641666 [TBL] [Abstract][Full Text] [Related]
9. Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats. Robison LS; Ananth M; Hadjiargyrou M; Komatsu DE; Thanos PK J Neural Transm (Vienna); 2017 May; 124(5):655-667. PubMed ID: 28116523 [TBL] [Abstract][Full Text] [Related]
10. MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates. Zhang X; Newport GD; Callicott R; Liu S; Thompson J; Berridge MS; Apana SM; Slikker W; Wang C; Paule MG Neurotoxicol Teratol; 2016; 56():68-74. PubMed ID: 27307090 [TBL] [Abstract][Full Text] [Related]
11. Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding. Jalloh K; Roeder N; Hamilton J; Delis F; Hadjiargyrou M; Komatsu D; Thanos PK Life Sci; 2021 Jan; 264():118708. PubMed ID: 33186568 [TBL] [Abstract][Full Text] [Related]
12. Chronic Methamphetamine Effects on Brain Structure and Function in Rats. Thanos PK; Kim R; Delis F; Ananth M; Chachati G; Rocco MJ; Masad I; Muniz JA; Grant SC; Gold MS; Cadet JL; Volkow ND PLoS One; 2016; 11(6):e0155457. PubMed ID: 27275601 [TBL] [Abstract][Full Text] [Related]
13. Chronic exposure to methylphenidate impairs appendicular bone quality in young rats. Komatsu DE; Thanos PK; Mary MN; Janda HA; John CM; Robison L; Ananth M; Swanson JM; Volkow ND; Hadjiargyrou M Bone; 2012 Jun; 50(6):1214-22. PubMed ID: 22465849 [TBL] [Abstract][Full Text] [Related]
14. Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration. Ding YS; Gatley SJ; Thanos PK; Shea C; Garza V; Xu Y; Carter P; King P; Warner D; Taintor NB; Park DJ; Pyatt B; Fowler JS; Volkow ND Synapse; 2004 Sep; 53(3):168-75. PubMed ID: 15236349 [TBL] [Abstract][Full Text] [Related]
15. MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates. Zhang X; Talpos J; Berridge MS; Apana SM; Slikker W; Wang C; Paule MG Neurotoxicol Teratol; 2021; 87():107017. PubMed ID: 34265415 [TBL] [Abstract][Full Text] [Related]
16. Enhanced Fear Memories and Altered Brain Glucose Metabolism ( Radford KD; Berman RY; Jaiswal S; Kim SY; Zhang M; Spencer HF; Choi KH Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163844 [TBL] [Abstract][Full Text] [Related]
17. Sex Differences in the Physiological and Behavioral Effects of Chronic Oral Methylphenidate Treatment in Rats. Robison LS; Michaelos M; Gandhi J; Fricke D; Miao E; Lam CY; Mauceri A; Vitale M; Lee J; Paeng S; Komatsu DE; Hadjiargyrou M; Thanos PK Front Behav Neurosci; 2017; 11():53. PubMed ID: 28400722 [TBL] [Abstract][Full Text] [Related]
18. Alcohol binge drinking decreases brain glucose metabolism and functional connectivity in adolescent rats. Rapp C; Hamilton J; Richer K; Sajjad M; Yao R; Thanos PK Metab Brain Dis; 2022 Aug; 37(6):1901-1908. PubMed ID: 35567647 [TBL] [Abstract][Full Text] [Related]
19. Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate. Michaelides M; Pascau J; Gispert JD; Delis F; Grandy DK; Wang GJ; Desco M; Rubinstein M; Volkow ND; Thanos PK Eur J Neurosci; 2010 Aug; 32(4):668-76. PubMed ID: 20646063 [TBL] [Abstract][Full Text] [Related]